Bayesian population analysis of a washin-washout physiologically based pharmacokinetic model for acetone. 2009

Anna-Karin Mörk, and Fredrik Jonsson, and Gunnar Johanson
Work Environment Toxicology, Institute of Environmental Medicine, Karolinska Institutet, SE-17177 Stockholm, Sweden. anna-karin.mork@ki.se

The aim of this study was to derive improved estimates of population variability and uncertainty of physiologically based pharmacokinetic (PBPK) model parameters, especially of those related to the washin-washout behavior of polar volatile substances. This was done by optimizing a previously published washin-washout PBPK model for acetone in a Bayesian framework using Markov chain Monte Carlo simulation. The sensitivity of the model parameters was investigated by creating four different prior sets, where the uncertainty surrounding the population variability of the physiological model parameters was given values corresponding to coefficients of variation of 1%, 25%, 50%, and 100%, respectively. The PBPK model was calibrated to toxicokinetic data from 2 previous studies where 18 volunteers were exposed to 250-550 ppm of acetone at various levels of workload. The updated PBPK model provided a good description of the concentrations in arterial, venous, and exhaled air. The precision of most of the model parameter estimates was improved. New information was particularly gained on the population distribution of the parameters governing the washin-washout effect. The results presented herein provide a good starting point to estimate the target dose of acetone in the working and general populations for risk assessment purposes.

UI MeSH Term Description Entries
D008390 Markov Chains A stochastic process such that the conditional probability distribution for a state at any future instant, given the present state, is unaffected by any additional knowledge of the past history of the system. Markov Process,Markov Chain,Chain, Markov,Chains, Markov,Markov Processes,Process, Markov,Processes, Markov
D008962 Models, Theoretical Theoretical representations that simulate the behavior or activity of systems, processes, or phenomena. They include the use of mathematical equations, computers, and other electronic equipment. Experimental Model,Experimental Models,Mathematical Model,Model, Experimental,Models (Theoretical),Models, Experimental,Models, Theoretic,Theoretical Study,Mathematical Models,Model (Theoretical),Model, Mathematical,Model, Theoretical,Models, Mathematical,Studies, Theoretical,Study, Theoretical,Theoretical Model,Theoretical Models,Theoretical Studies
D009010 Monte Carlo Method In statistics, a technique for numerically approximating the solution of a mathematical problem by studying the distribution of some random variable, often generated by a computer. The name alludes to the randomness characteristic of the games of chance played at the gambling casinos in Monte Carlo. (From Random House Unabridged Dictionary, 2d ed, 1993) Method, Monte Carlo
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000096 Acetone A colorless liquid used as a solvent and an antiseptic. It is one of the ketone bodies produced during ketoacidosis.
D001499 Bayes Theorem A theorem in probability theory named for Thomas Bayes (1702-1761). In epidemiology, it is used to obtain the probability of disease in a group of people with some characteristic on the basis of the overall rate of that disease and of the likelihood of that characteristic in healthy and diseased individuals. The most familiar application is in clinical decision analysis where it is used for estimating the probability of a particular diagnosis given the appearance of some symptoms or test result. Bayesian Analysis,Bayesian Estimation,Bayesian Forecast,Bayesian Method,Bayesian Prediction,Analysis, Bayesian,Bayesian Approach,Approach, Bayesian,Approachs, Bayesian,Bayesian Approachs,Estimation, Bayesian,Forecast, Bayesian,Method, Bayesian,Prediction, Bayesian,Theorem, Bayes
D035501 Uncertainty The condition in which reasonable knowledge regarding risks, benefits, or the future is not available.

Related Publications

Anna-Karin Mörk, and Fredrik Jonsson, and Gunnar Johanson
May 1995, Occupational and environmental medicine,
Anna-Karin Mörk, and Fredrik Jonsson, and Gunnar Johanson
January 2010, Journal of toxicology and environmental health. Part A,
Anna-Karin Mörk, and Fredrik Jonsson, and Gunnar Johanson
October 2006, Regulatory toxicology and pharmacology : RTP,
Anna-Karin Mörk, and Fredrik Jonsson, and Gunnar Johanson
October 2001, Toxicological sciences : an official journal of the Society of Toxicology,
Anna-Karin Mörk, and Fredrik Jonsson, and Gunnar Johanson
December 2003, Journal of toxicology and environmental health. Part A,
Anna-Karin Mörk, and Fredrik Jonsson, and Gunnar Johanson
February 2012, Antimicrobial agents and chemotherapy,
Anna-Karin Mörk, and Fredrik Jonsson, and Gunnar Johanson
January 2008, Journal of toxicology and environmental health. Part A,
Anna-Karin Mörk, and Fredrik Jonsson, and Gunnar Johanson
March 2021, Ecotoxicology and environmental safety,
Anna-Karin Mörk, and Fredrik Jonsson, and Gunnar Johanson
January 2008, Clinical pharmacokinetics,
Copied contents to your clipboard!